A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)
Clinical trial NCT02985879 · TERMINATED
Trial details
- NCT number
- NCT02985879
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2019-11-20
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.